GORE EXCLUDER Conf AAA Endo - Trunk-Ipsilateral CXT281212Recalls & reported problems
W. L. Gore & Associates, Inc. · EXCLUDER CONFORM AAA TRNK ENDO 28.5mmX12mmX12cm 16Fr · Class 3 · Implant
All models of GORE EXCLUDER Conf AAA Endo - Trunk-Ipsilateral (10)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00733132651047), received between Sep 9, 2022 and Sep 9, 2022 — classified as 1 malfunction.
The most frequently reported specific device problem is “Difficult or Delayed Activation” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Difficult or Delayed Activation1
- Difficult to Fold, Unfold or Collapse1
- Material Deformation1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 9, 2022Difficult to Fold, Unfold or Collapse; Difficult to Fold, Unfold or Collapse; Difficult or Delayed Activation; Material Deformation
ON (B)(6) 2022, THE PATIENT WAS ADMITTED FOR ENDOVASCULAR AORTIC REPAIR OF AN ABDOMINAL AORTIC ANEURYSM USING A GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESIS. REPORTEDLY, DURING DEPLOYMENT THE DEVICE WAS RECONSTRAINED FOUR SEPARATE TIMES. AS REPORTED, EACH TIME THE DEVICE WAS RECONSTRAINED IT REOPENED WITH ONE SIDE SLIGHTLY LOWER (1960-E:-OTHER/UNKNOWN). AS REPORTED, FOLLOWING THE FOURTH ATTEMPT TO REPOSITION AND REOPEN THE ENDOPROSTHESIS THE PHYSICIAN DECIDED TO PROCEED BY LEAVING THE ENDOPROSTHESIS WHERE IT WAS, WITH ONE SIDE OF THE LEADING EDGE SLIGHTLY LOWER, AND ADDED A GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESIS AORTIC EXTENDER COMPONENT. THE PATIENT WAS TREATED EFFECTIVELY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15396871 ↗
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page